Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 601-490-4 | CAS number: 117704-25-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames assay: Negative result (Amacher, 1991).
Mammalian cell gene mutation assay: Negative result (Amacher, 1991).
Unscheduled DNA synthesis assay: Negative result (Amacher, 1991).
Link to relevant study records
- Endpoint:
- in vitro DNA damage and/or repair study
- Remarks:
- Type of genotoxicity: DNA damage and/or repair
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From Aug to Sep 1987
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study run to a method comparable with current guidelines and to GLP
- Qualifier:
- according to guideline
- Guideline:
- other: Mutation Research 123: 363-410
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- DNA damage and repair assay, unscheduled DNA synthesis in mammalian cells in vitro
- Species / strain / cell type:
- hepatocytes: rat
- Test concentrations with justification for top dose:
- Preliminary cytotoxicity test: 10.0, 20.0, 40.0, 60.0, 80.0, 100.0 and 200.0 μg/mL;
Definitive test: 1.7, 5.0, 7.5, 10.0, 15.0, 20.0 μg/mL - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The primary choice of solvent is an aqueous solvent (culture medium or saline) due to their non-toxic properties in mammalian cultures. An alternative choice is a non-toxic concentration of an organic solvent such as dimethylsulfoxide (DMSO) or ethyl alcohol (ETOH). - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- no
- Remarks:
- Preliminary cytotoxicity test
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-acetylaminofluorene
- Remarks:
- Definitive test
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Preincubation period:
- Exposure duration: Preliminary cytotoxicity test: 18-20 hours; Definitive test: 18-20 hours
- Expression time (cells in growth medium):
- Selection time (if incubation with a selection agent):
- Fixation time (start of exposure up to fixation or harvest of cells): 10 mins
SELECTION AGENT (mutation assays):
SPINDLE INHIBITOR (cytogenetic assays):
STAIN (for cytogenetic assays): trypan blue
NUMBER OF REPLICATIONS: Preliminary cytotoxicity test: duplicate; Definitive test: four
NUMBER OF CELLS EVALUATED: Preliminary cytotoxicity test: At least one hundred attached cells; Definitive test: One culture from each treatment group counted at least 100 attached cells for viability, then at least 1000 non S-phase nuclei were scored for UDS from each cultre.
DETERMINATION OF CYTOTOXICITY
- Method: relative survival
OTHER EXAMINATIONS:
- Determination of polyploidy:
- Determination of endoreplication:
- Other:
OTHER: - Evaluation criteria:
- A positive nucleus is one that has >4 net nuclear grain count. The criteria used for deermining a positive result is a statistically significant, reproducible and dose-related increase in the number of positive nuclei compared to the test solvent controls and the negative historical controls.
- Statistics:
- For statistical analysis, a two sample t-test is performed to determine significance.
- Species / strain:
- hepatocytes: rat
- Metabolic activation:
- not applicable
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- up to 10 μg/mL
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- In the evaluation of the preliminary cytotoxicity of test substance, there was a substantial reduction in cell viability at 20 μg/mL. Test substance at ≥ 40.0 μg/mL, was toxic to the cultures. There was evidence of insolubility in the cultures at test concentrations of ≥ 60.0 μg/mL.
For the UDS assay, at test concentrations at 1.7, 5.0 and 7.5 μg/mL, there was no increase in UDS compared to the concurrent solvent controls. Test substanse at 10.0 μg/mL produced insufficient viability (less than 25%) and therefore should not be considered in the UDS evaluation. A two sample t-test performed at concentrations of 1.7, 5.0, and 7.5 μg/mL, indicated there was no statistically significant difference (at the p≤5 level) in the number of positive cells between the solvent controls and the treated cultures. Test substance at ≥ 15.0 μg/mL was toxic to the cultures. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative
These studies indicate that the test substance does not induce UDS in primary cultures of rat hepatocytes at concentrations which produce marked reductions in cell viabilities. - Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From August to October 1987
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study run to a method comparable with current guidelines and to GLP
- Qualifier:
- according to guideline
- Guideline:
- other: Mutation Research 113:173-215,1983
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine gene in S. typhimurium
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- Without S9 mix: 0.02, 0.1, 0.5, 2.0, 10.0 mg/plate for all strains
With S9 mix: 0.005, 0.02, 0.1, 0.5, 2.0 mg/plate for all strains - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: sodium nitrite
- Remarks:
- In the absence of S9 mix for TA 1535 strain
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- In the absence of S9 mix for TA 1537 strain
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- In the absence of S9 mix for TA 98 strain
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Nitrofurantoin
- Remarks:
- In the absence of S9 mix for TA 100 strain
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-Anthramine
- Remarks:
- In the presence of S9 mix for all strains
- Details on test system and experimental conditions:
- Triplicate plates were prepared at each level, incubated for at least 60 hours at 37 ℃ and the number of revertant colonies per plate was recorded. Mutagenic activity induced by the compound was detected by reversion to prototrophy (histidine independence). The average number of revertant colonies per plate with the test compound was compared to the average number of spontaneous revertant colonies per control plate.
- Evaluation criteria:
- A dose-related, reproducible three-fold increase over control value is considered a positive response. Responses up to two-fold are occasionally noted in some assays but are not considered indicative of mutagenicity.
- Statistics:
- None stated.
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- There was no evidence of compound-related increases in the number of revertant colonies per plate at any level of the test substance with strains TA 1535, TA 1537, TA 98 and TA 100 that would suggest mutagenic activity. A level of 2 mg/plate and higher showed insoluble compound in the overlay. No evidence of metabolic activation of the compound to a mutagen was found with the same strains. No mutagenic excretory product was found in urine from mice dosed intraperitoneally with 0.2, 2 or 4 mg/kg. In all assays, negative and positive controls performed within expected historical ranges.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative
These studies demonstrated that the test substance does not induce reversion in frameshift or base-substitution Salmonella strains either directly or after metabolic activation by liver S9 fraction from Aroclor-induced mice or rats. Each plate incorporation assay with and without S9 contained at least one level showing insoluble compound. No mutagenic excretory products were detected in urine of mice dosed with test substance. The results presented in this report meet the criteria for an acceptable assay. - Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 13 to 20 July 1987
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study run to a method comparable with current guidelines and to GLP
- Qualifier:
- according to guideline
- Guideline:
- other: Amacher and Turner, Mutat. Res. 97:49-65, 1982
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- thymidine kinase
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- without S9 mix: 8-35 μg/mL
with S9 mix: 13-62 μg/mL - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: Most test articles are freely soluble in DMSO, and our previous experience has demonstrated that 1% DMSO in the final test or control culture has no effect on cell viability or mutant frequency at the TK locus. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 3-methylcholanthrene
- Remarks:
- In the presence of S9 mix
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- In the absence of S9 mix
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in suspension
DURATION
- Preincubation period:
- Exposure duration: three hours
- Expression time (cells in growth medium): 48 hours
- Selection time (if incubation with a selection agent): 7-12 days
- Fixation time (start of exposure up to fixation or harvest of cells):
SELECTION AGENT (mutation assays): trifluorothymidine
SPINDLE INHIBITOR (cytogenetic assays):
STAIN (for cytogenetic assays):
NUMBER OF REPLICATIONS: triplicate
NUMBER OF CELLS EVALUATED: 1E+06 cells/plate
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
OTHER EXAMINATIONS:
- Determination of polyploidy:
- Determination of endoreplication:
- Other:
OTHER: - Evaluation criteria:
- A positive mutagenic response is indicated when 3 or more data points (3 concentrations of the test article which ultimately produced mutagenicity and cytotoxicity data) are obtained with all of the following characteristics:
1. Total relative growth (a measure of cell survival defined in the Standard Laboratory Procedures) between 20-80%.
2. Calculated mutant frequencies greater than the mutant frequencies for concomitant solvent controls. The observation of a positive correlation between test article concentration and increasing mutant frequencies over some interval within a range of test article concentrations producing 20-80% total relative growth, should be possible. A positive slope derived from linear regression analysis of the data defined in III.A.1.a. where test article concentration is in molarity units.
3. An absolute mean mutant yield (average number of TFTr colonies/plate) for all dose levels of the test article meeting criteria IIl.A.1 .significantly (p<0.05) greater than the corresponding average mutant yield for concomitant solvent controls.
4. Calculated mutant frequencies for experimental data which meet criterion III.A.1. must also exceed the range of acceptable responses for solvent control mutant frequencies (8-47E-6 survivors) defined in Il.A.2. - Statistics:
- 1. A two sample t-test is performed using pooled mutant counts from solvent controls (c) and treated cuftures(t) where%growth > 20 and < 100%. The t value equals the difference in sample means (Xc - Xt) divided by the pooled variance (Sp) times the square root of 1/nc+ 1/nt where n=total sample items for control and treated groups respectively.
2. A positive mutagen produces a progressive increase in absolute mutant recovery concomitant with a gradual decrease in cloning efficiency. Data where absolute cloning efficiencies for treated cultures <50% should not be used.
3. A test is positive if P ≤ 0.05 and the ratio of the treated/control geometric mean number of mutants/plate ≥ 1.26. - Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- up to 18 μg/mL without S9 and up to 32 μg/mL with S9
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The test substance did not produce a mutagenic response in the concentration range of 8-35 μg/mL and total relative growth range of 3-91%. In the presence of exogenous metabolic activation the drug-induced cytotoxicity was greatly decreased in the concentration range of 13-51 μg/mL and the test substance was not metabolized to a mutagen. Results obtained for the two test concentrations of 3MCA were within the range of historical positive control data obtained in this laboratory indicating that the S9 activation mix was enzymatically active. The test substance caused no significant dose-related elevation of mutant frequency beyond the acceptable historical ranges for solvent controls of 8-47 E+6 survivors (no S9) and 9-41E+6 survivors (S9) and absolute cloning efficiencies were >70% but <120%. The positive control mutant frequency values were well within the acceptable historical ranges for EMS (no S9) of 500-1307E+6 survivors at 621 μg/mL and 49-191E+6 survivors at 62 μg/mL and for 3-MCA (S9) of 70-421E+6 survivors at 5.37 μg/mL and 47-208E+6 survivors at 2.69 μg/mL.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative
The test substance did not produce a mutagentic response in the absence of S9. In the presence of rat S9, the test substance was not activated to a mutagen in the L5178Y/TK point mutation assay.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Micronucleus assay: Negative result (Holden, 1991).
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- August 1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study run to a method comparable with current guidelines and to GLP .
- Qualifier:
- according to guideline
- Guideline:
- other: Schlegel and MacGregor, (Mutation Res. 104:367-369, 1982), MacGregor et al., (Ibid. 189: 103-112, 1987) and Heddle et al., (Ibid 123:61-118, 1983)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:
- Age at study initiation:
- Weight at study initiation: 30±5 grams
- Assigned to test groups randomly: yes
- Fasting period before study:
- Housing:
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period:
ENVIRONMENTAL CONDITIONS
- Temperature (°C):
- Humidity (%):
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light):
IN-LIFE DATES: From: To: - Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: distill water containing 5% methylcellulose
- Justification for choice of solvent/vehicle:
- Concentration of test material in vehicle:
- Amount of vehicle (if gavage or dermal):0.3 mL/30 g
- Type and concentration of dispersant aid (if powder):
- Lot/batch no. (if required):
- Purity: - Duration of treatment / exposure:
- three days
- Frequency of treatment:
- once per day
- Post exposure period:
- 24 hours
- Remarks:
- Doses / Concentrations:
500, 1000 and 2000 mg/kg/day
Basis:
actual ingested - No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Mitomycin C
- Route of administration: i.p. adminstration
- Doses / concentrations: 0.5 mg/kg/day - Tissues and cell types examined:
- For each preparation, 1000 PCEs (polychromatic erythrocyte) were scored for presence of micronuclei. Also, the ratio of PCE to NCE (normochromatic erythrocytes) in 200 erythrocytes was determined as an index of cytotoxicity.
- Details of tissue and slide preparation:
- Twenty-four hours after the final treatment, mice were sacrificed by cervical dislocation and swears were made from the bone marrow of the femora from each mouse. At least two slides were prepared. Slides were fixed in absolute methanol within one hour of collection and were then coded hy independent technician. Immediately prior to scoring, slides were stained 1-3 minutes in acridine orange (0.125 mg/mL) in phosphate buffer, rinsed in buffer and coverslips were mounted in the buffer.
- Evaluation criteria:
- A positive response is defined as a substantial, dose-related and reproducible elevation in the number of micronucleated PCEs in the treated animals. Where a positive response is indicated, statistical analysis can be conducted using a one-tailed trend test and also a pairwise comparison of the results for each treatment group with the concurrent negative control (Margolin et al., A general purpose statistical analysis program for the micronucleus assay-working document. ILS Committee for the Development of a Software Program for the Micronucleus Assay, 1990).
- Statistics:
- None stated
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- Drug-associated reduction in the percent of PCEs
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The frequencies of MNPCE at all dose levels of test substance are within the acceptable historical negative control limits. Positive controls showed a significant elevation in micronucleated PCEs in accordance with historical control data. Negative controls showed expected results. There was evidence of drug-related bone marrow toxicity as indicated by a dose-related decrease in percent PCEs. There was no substantial increase in micronucleated PCEs. The test substance produced a dose-related decrease in the percentage of PCEs indicating drug-related toxicity.
- Conclusions:
- Interpretation of results (migrated information): negative
These studies demonstrate that the test subsance does not induce micronuclei in PCEs in bone marrow in male or female mice. Drug-associated reduction in the percent of PCEs in both sexes confirms that the dose level used were at or near the maximum tolerated dose.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
In vitro:
Three in vitro studies available.
Ames assay: These studies demonstrated that the test substance does not induce reversion in frameshift or base-substitution Salmonella strains either directly or after metabolic activation by liver S9 fraction from Aroclor-induced mice or rats (Amacher, 1991).
Mammalian cell gene mutation assay: The test substance did not produce a mutagentic response in the absence of S9. In the presence of rat S9, the test substance was not activated to a mutagen in the L5178Y/TK point mutation assay (Amacher, 1991).
Unscheduled DNA synthesis assay: These studies indicate that the test substance does not induce UDS in primary cultures of rat hepatocytes at concentrations which produce marked reductions in cell viabilities (Amacher, 1991).
In vivo:
Micronucleus assay: These studies demonstrate that the test subsance does not induce micronuclei in PCEs in bone marrow in male or female mice. Drug-associated reduction in the percent of PCEs in both sexes confirms that the dose level used were at or near the maximum tolerated dose (Holden, 1991).
Justification for classification or non-classification
All in vitro and in vivo studies resulted in negative result.
Therefore in accordance with Regulation (EC) No. 1272/2008 Table 3.5.1, this substance should not be classified as germ cell mutagens.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.